23 completed. 23 Phase 2, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 23 | Completed 23 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 2 | Completed 2 |
Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adrenomedullin for CADASIL Adrenomedullin - Cadasil | Phase 2 | Completed | National Cerebral and Cardiovascular Center, Japan | 60 | 2022-01-06 | 2023-10-10 |
| Efficacy and Safety of Tocotrienols in CADASIL HOV-12020 (Palm tocotrienols complex), Placebo - Cadasil | Phase 2 | Completed | Hovid Berhad | 50 | 2020-12-21 | 2026-02-02 |
| Fluoxetine Opens Window to Improve Motor Recovery After Stroke Fluoxetine Hydrochloride, Placebo, Exercise Program - Stroke, Cerebrovascular Accident | Phase 2 | Completed | University Health Network, Toronto | 52 | 2019-01-01 | 2022-11-04 |
| Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2) Tenecteplase - Ischemic Stroke | Phase 2 | Completed | Neuroscience Trials Australia | 300 | 2017-12-06 | 2020-03-04 |
| Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset Neu2000KWL, Placebos - Stroke, Cerebral Infarction | Phase 2 | Completed | Beijing Tiantan Hospital | 236 | 2017-03-02 | 2020-07-24 |
| Transcranial Direct Current Stimulation Associate to Constraint Induced Movement Therapy Over Premotor Cortex in Severe Stroke Transcranial direct current stimulation, Constraint-Induced Movement Therapy - Stroke, Cerebrovascular Disorders | Phase 1 / Phase 2 | Completed | Federal University of Paraíba | 60 | 2016-01-01 | 2016-04-05 |
| Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction Cordstem-ST, Placebo - Cerebral Infarction | Phase 1 / Phase 2 | Completed | CHABiotech CO., Ltd | 18 | 2015-02-01 | 2024-04-09 |
| Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Allogenic mesenchymal stem cells from adipose tissue, Placebo - Ischemic Stroke | Phase 2 | Completed | Instituto de Investigación Hospital Universitario La Paz | 19 | 2014-09-01 | 2018-02-28 |
| Pilot Investigation of Stem Cells in Stroke Phase II Efficacy CTX DP - Ischaemic Stroke, Cerebral Infarction | Phase 2 | Completed | ReNeuron Limited | 23 | 2014-06-01 | 2018-07-23 |
| Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase Human Urinary Kallidinogenase, Shuxuening injection - Cerebral Infarction | Phase 2 | Completed | XuanwuH 2 | 120 | 2013-01-01 | 2014-10-08 |
| Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke Autologous BMSCs transplantation, Autologous EPCs transplantation, IV infusion of placebo - Stroke, Infarction, Middle Cerebral Artery | Phase 1 / Phase 2 | Completed | Southern Medical University, China | 20 | 2011-11-01 | 2021-04-02 |
| Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) - Cerebral Infarction, Brain Ischemia | Phase 2 | Completed | University of Alberta | 20 | 2009-10-01 | 2018-04-06 |
| Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients Intercerebral implantation of Autulogous Stem Cells, convention therapy - Stroke, Middle Cerebral Artery Infarction | Phase 2 | Completed | China Medical University Hospital | 30 | 2009-06-01 | 2011-04-21 |
| Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study MindFrame System - Ischemic Stroke | Phase 2 | Completed | MindFrame, Inc. | 40 | 2009-03-01 | 2012-07-26 |
| Action of Amantadine on Post-Stroke Aphasic Patients Amantadin, Placebo - Cerebral Infarction | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 50 | 2009-03-01 | 2014-04-21 |
| Stem Cell Therapy For Acute Ischemic Stroke Patients BMSCs - Middle Cerebral Artery Infarction, Anterior Cerebral Artery Infarction | Phase 2 | Completed | All India Institute of Medical Sciences | 120 | 2009-01-01 | 2015-04-24 |
| Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund) TH - Endovascular alone (Alsius®, Zoll, USA), TH - Endovascular + nasopharyngeal induction (Alsius®, Zoll, USA) (Rhinochill®, Benechill, USA), Intravenous cold saline and surface cooling (Arctic Sun, Medivance, USA) - Cerebral Infarction | Phase 2 | Completed | Bispebjerg Hospital | 31 | 2008-10-01 | 2011-12-28 |
| Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Deferoxamine - Ischemic Stroke, Acute | Phase 2 | Completed | Germans Trias i Pujol Hospital | 62 | 2008-09-01 | 2022-08-08 |
| Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Infusion on autologous CD34+ stem cells into middle cerebral artery - Stroke, Acute, Infarction, Middle Cerebral Artery | Phase 1 / Phase 2 | Completed | Hospital Universitario Central de Asturias | 20 | 2008-09-01 | 2011-11-29 |
| Study of NeuroAid In Enhancing Recovery After Stroke Neuroaid, Neuroaid matched Placebo - Stroke, Cerebral Infarction | Phase 2 | Completed | Moleac Pte Ltd. | 40 | 2008-01-01 | 2008-07-24 |
Showing 20 of 23. Sign in to see all of them.
Stroke (16) · Infarction, Middle Cerebral Artery (7) · Ischemic Stroke (6) · Central Nervous System Diseases (4) · Cerebrovascular Disorders (4) · Brain Ischemia (3) · Vascular Diseases (3) · Brain Diseases (2) · Brain Infarction (2) · CADASIL (2) · Ischemia (2) · Nervous System Diseases (2) · Aphasia (1) · Cardiovascular Diseases (1)
Infarction (23) · Necrosis (23) · Pathological Conditions, Signs and Symptoms (23) · Cardiovascular Diseases (22) · Pathologic Processes (22) · Brain Diseases (21) · Brain Infarction (21) · Ischemia (21) · Nervous System Diseases (21) · Brain Ischemia (20) · Vascular Diseases (20) · Central Nervous System Diseases (19) · Cerebrovascular Disorders (19) · Cerebral Arterial Diseases (9) · Intracranial Arterial Diseases (9)
Tenecteplase (2) · Adrenomedullin (1) · Amantadine (1) · Aspirin (1) · Constraint Induced Movement Therapy (1) · Deferoxamine (1) · Fluoxetine (1) · Injections (1) · Methods (1) · Neuroaid (1) · Resistance Training (1) · Saline Solution (1) · Sugars (1) · Tocotrienols (1) · Transcranial Direct Current Stimulation (1)
All India Institute of Medical Sciences (1) · Beijing Tiantan Hospital (1) · Bispebjerg Hospital (1) · CHABiotech CO., Ltd (1) · Centre Hospitalier Universitaire de Nice (1) · China Medical University Hospital (1) · Federal University of Paraíba (1) · Germans Trias i Pujol Hospital (1) · Hospital Universitario Central de Asturias (1) · Hovid Berhad (1) · Imperial College London (1) · Instituto de Investigación Hospital Universitario La Paz (1) · Max-Planck-Institute of Experimental Medicine (1) · Merck Sharp & Dohme LLC (1) · MindFrame, Inc. (1)
China (3) · Spain (3) · Canada (2) · France (2) · Germany (2) · United Kingdom (2) · Australia (1) · Brazil (1) · Denmark (1) · India (1) · Japan (1) · New Zealand (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Bradley MacIntosh, PhD (1) · Courtney Pollock, PhD (1) · David Ho (1) · Kameshwar Prasad, MBBS, MD (1) · Keith W Muir (1) · Keng He Kong, MD (1) · Kenneth Butcher, MD, PhD (1) · Marilyn Mackay-Lyons, PhD (1) · Mark Bayley, MD (1) · Martin Bendszus, MD, PhD (1) · Meng Wang, MD, Ph.D (1) · Michelle Ploughman, PhD (1)
PMID 22163120, PMID 19834012, PMID 20947374, PMID 21852153, PMID 22764211, PMID 25107583, PMID 25304723, PMID 25378424, PMID 25938519, PMID 26752061, PMID 30156755, PMID 31564231, PMID 32078683, PMID 33236783, PMID 33408145, PMID 34439518, PMID 34906976, PMID 35017305, PMID 36289001, PMID 36878701, PMID 38502892, PMID 38768068, PMID 42005919